Immune response against large tumors eradicated by treatment with cyclophosphamide and IL-12

Journal of Immunology

Volumn 160, Issue 3, 1998, Pages 1369-1377

  Tsung, Kangla ^a   Meko, Jennifer B ^a   Tsung, Ying L ^a   Peplinski, Gary R ^a   Norton, Jeffrey A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; CYCLOPHOSPHAMIDE; FLUOROURACIL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER TRANSPLANTATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG CYTOTOXICITY; ERADICATION THERAPY; FEMALE; HELPER CELL; IMMUNE RESPONSE; IMMUNOPOTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA; SPLEEN CELL; TUMOR IMMUNITY; TUMOR REGRESSION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; FEMALE; INTERFERON TYPE II; INTERLEUKIN-12; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SARCOMA, EXPERIMENTAL; T-LYMPHOCYTES;

EID: 0031893260     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Brunda, M. J., L. Luistro, R. R. Warrier, R. B. Wright, B. R. Hubbard, M. Murphy, S. F. Wolf, and M. K. Gately. 1993. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178:1223.
2. Nastala, C. L., H. D. Edington, T. G. McKinney, H. Tahara, M. A. Nalesnik, M. J. Brunda, M. K. Gately, S. F. Wolf, R. D. Schreiber, W. J. Storkus, and M. T. Lotze. 1994. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153:1697.
3. Mu, J., J.-P. Zou, N. Yamamoto, T. Tsutsui, X.-G. Tai, M. Kobayashi, S. Herrmann, H. Fujiwara, and T. Hamaoka. 1995. Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes. Cancer Res. 55:4404.
4. Noguchi, Y., E. C. Richards, Y.-T. Chen, and L. J. Old. 1995. Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. Proc. Natl. Acad. Sci. USA 92:2219.
5. Tsung, K., J. B. Meko, G. R. Peplinski, Y. Tsung, and J. A. Norton. 1997. IL-12 induces T helper 1-directed antitumor response. J. Immunol. 158:3359.
6. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of T cells. Immunol. Today 14:335.
7. Wolf, S. F., P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R. M. Hewick, K. Kelleher, S. H. Herrmann, S. C. Clark, L. Azzoni, S. H. Chan, G. Trinchieri, and B. Perussia. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146:3074.
8. Seder, R. A., R. Gazzinelli, A. Sher, and W. E. Paul. 1993. Interleukin 12 acts directly on CD4 T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
9. Chouaib, S., J. Chehimi, L. Bani, N. Genetet, T. Tursz, F. Gay, G. Trinchieri, and F. Mami-Chouaib. 1994. Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors. Proc. Natl. Acad. Sci. USA 91:12659.
10. Sgadari, C., A. L. Angiolillo, and G. Tosato. 1996. Inhibition of Angiogenesis by interleukin-12 is mediated by the γ interferon-inducible protein 10. Blood 87: 3877.
11. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
12. Perry, L. L., K. Feilzer, and H. D. Caldwell. 1997. Immunity to chlamydia trachomatis is mediated by T helper 1 cells through IFNγ-dependent and -independent pathways. J. Immunol. 158:3344.
13. Taylor, A. P., and H. W. Murray. 1997. Intracellular antimicrobial activity in the absence of interferon-γ: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-γ gene-disrupted mice. J. Exp. Med. 185:1231.
14. Mitsuoka, A., M. Baba, and S. Morikawa. 1976. Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in mice. Nature 262:77.
15. Young, R. C. 1976. Kinetic aids to proper chemotherapeutic scheduling: labeled nucleoside incorporation studies in vivo. Cancer Treat. Rep. 60:1947.
16. Hengst, J. C. D., M. B. Mokyr, and S. Dray. 1980. Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice. Cancer Res. 40: 2135.
17. Awwad, M., and R. J. North. 1989. Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4 suppressor T-cells. Cancer Res. 49:1649.
18. Car, B. D., V. M. Eng, B. Schnyder, M. LeHir, A. N. Shakhov, G. Woerly, S. Huang, M. Aguet, T. D. Anderson, and B. Ryffel. 1995. Role of interferon-γ in interleukin 12-induced pathology in mice. Am. J. Pathol 147:1693.
19. Yu, W.-G., N. Yamamoto, H. Takenaka, J. Mu, X.-G. Tai, J.-P. Zou, M. Ogawa, T. Tsutsui, R. Wijesuriya, R. Yoshida, S. Herrmann, H. Fujiwara, and T. Hamaoka. 1996. Molecular mechanisms underlying IFN-γ mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12. Int. Immunol. 8:855.
20. Tannenbaum, C. S., N. Wicker, D. Armstrong, R. Tubbs, J. Finke, R. M. Bukowski, and T. A. Hamilton. 1996. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. J. Immunol. 156:693.
21. Evans, R. 1980. Further observations on the effect of cyclophosphamide on intratumor and peripheral leukocyte levels. Am. J. Pathol. 99:667.
22. Dye, E. S., and R. J. North. 1980. Macrophage accumulation in murine ascites tumors: Cytoxan-induced dominance of macrophages over tumor cells and the anti-tumor effect of endotoxin. J. Immunol. 125:1650.
23. Wigginton, J. M., K. L. Komschlies, T. C. Back, J. L. Franco, M. J. Brunda, and R. H. Wiltrout. 1996. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma. J. Natl. Cancer Inst. 88:38.
24. Barth, R. J., S. N. Bock, J. J. Mule and S. A. Rosenberg. 1990. Unique tumor-associated antigen identified by tumor infiltrating lymphocytes. J. Immunol. 144: 1531.
25. Peng, L., S. S. Shu, and J. C. Krauss. 1997. Treatment of subcutaneous tumor with adoptively transferred T cells. Cell. Immunol. 178:24.
26. Berendt, M. J., R. J. North, and D. P. Kirstein. 1978. The immunological basis of endotoxin-induced tumor regression. J. Exp. Med. 148:1560.
27. Skeen, M. J., M. A. Miller, T. M. Shinnick, and H. K. Ziegler. 1996. Regulation of murine macrophage IL-12 production. J. Immunol. 156:1196.
28. Hillman, G. G., E. Younes, D. Visscher, E. Ali, J. S. Lam, E. Montecillo, J. E. Pontes, G. P. Hasa, and R. K. Puri. 1995. Systemic treatment with interleukin-4 induces regression of pulmonary metastases in a murine renal cell carcinoma model. Cell. Immunol. 160:257.
29. Hosokawa, M., Y. Sawamura, T. Morkage, F. Okada, Z.-Y. Xu, K. Morikawa, K. Itoh, and H. Kobayashi. 1988. Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide. Cancer Immunol. Immunother. 26:250.
30. Kedar, E., R. Ben-Aziz, E. Epstein, and B. Leshem. 1989. Chemo-immunotherapy of murine tumors using interleukin-2(IL-2) and cyclophosphamide. Cancer Immunol. Immunother. 29:74.
31. Peppoloni, S., B. J. Mathieson, R. B. Herberman, R. W. Overton, and E. Gorelik. 1987. In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets. Cancer Immunol. Immunother. 24:49.
32. Dye, E. S., and R. J. North. 1984. Adoptive immunization against an established tumor with cytolytic versus memory T cells. Transplantation 37:600.
33. Yeager, A. M., F. C. Levin, and J. Levin. 1982. Effects of cyclophosphamide on murine bone marrow and splenic megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels. J. Cell. Physiol. 112:222.
34. Kaufmann, S. H. E., H. Hahn, and T. Diamantstein. 1980. Relative susceptibilities of T cell subsets involved in delayed-type hypersensitivity to sheep red blood cells to the in vitro action of 4-hydroperoxycyclophosphamide. J. Immunol. 125: 1104.
35. Bertagnolli, M. M., B.-Y. Lin, D. Young, and S. H. Herrmann. 1992. IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J. Immunol. 149:3778.